Codes / ICD10CM / D19.7

D19.7 Benign neoplasm of mesothelial tissue of other sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Benign neoplasm of mesothelial tissue of other sites
  • Also known as non-cancerous growths originating from mesothelial cells in locations other than the pleura, peritoneum, or pericardium.

Summary

Benign neoplasm of mesothelial tissue of other sites refers to non-cancerous tumors that arise from mesothelial cells, which line body cavities and organs. These growths are localized, do not invade surrounding tissues, and do not spread to other parts of the body. They are typically slow-growing and may be discovered incidentally during imaging or surgical procedures for unrelated conditions.

Causes

The exact cause of benign mesothelial neoplasms is not fully understood, but they may develop due to genetic mutations or chronic irritation of mesothelial cells. Unlike malignant mesotheliomas, these benign tumors are not linked to asbestos exposure or other known carcinogens.

Risk Factors

  • Age (more common in adults)
  • Prior surgical or inflammatory conditions affecting mesothelial tissues
  • Genetic predisposition (rare)

Symptoms

  • Often asymptomatic and discovered incidentally
  • May cause localized pain or discomfort if the tumor presses on nearby structures
  • Swelling or a palpable mass in the affected area (depending on location)

Diagnosis

Diagnosis typically involves imaging studies (e.g., CT, MRI) to identify the tumor and assess its location. A biopsy is usually performed to confirm the benign nature of the growth, as mesothelial neoplasms can sometimes mimic malignant conditions. Pathological examination of tissue samples is essential to rule out malignancy.

Treatment Options

  • Observation for small, asymptomatic tumors
  • Surgical removal for larger or symptomatic growths
  • Monitoring with periodic imaging to ensure no changes in size or behavior

Prognosis and Follow-Up

The prognosis for benign mesothelial neoplasms is excellent, as they do not spread or become cancerous. Most patients require no further treatment after removal. Follow-up care may include periodic imaging to ensure the tumor does not recur, especially if it was partially removed or if the patient has risk factors for new growths.

Complications

  • Rarely, large tumors may compress nearby organs, causing functional issues
  • Surgical removal carries standard risks, such as infection or bleeding
  • Misdiagnosis as a malignant tumor if biopsy results are unclear

Lifestyle & Prevention

  • No specific lifestyle changes are required, as these tumors are not preventable
  • Avoiding known irritants (e.g., asbestos) is important for overall mesothelial health but does not prevent benign neoplasms
  • Regular medical check-ups for those with a history of mesothelial conditions

When to Seek Professional Help

  • Persistent or worsening pain in the affected area
  • Noticeable swelling or a new mass
  • Symptoms that interfere with daily activities (e.g., breathing difficulties, digestive issues)
  • Follow-up imaging shows growth or changes in the tumor

Tips for Medical Coders

  • Code D19.7 is used for benign neoplasms of mesothelial tissue in sites other than the pleura, peritoneum, or pericardium. Documentation should specify the location (e.g., pericardium, tunica vaginalis) to support the code. Ensure the diagnosis confirms benignity, as malignant mesotheliomas use different codes. Verify that the tumor is not associated with asbestos exposure, as this may affect coding or reporting requirements.
Book a walkthrough

D19.7 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.